4th iPSC Drug Development & Manufacturing Summit

With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment. The 4th iPSC Drug Development & Manufacturing Summit is your longest standing and definitive iPSC focused industry platform showcasing cutting-edge advances across R&D through to manufacturing and analytical development to help you stay at the forefront of the iPSC cell therapy revolution. With content split across our Research & Development and Manufacturing & Analytical Development tracks, this is the one-stop shop meeting for drug developers and academic thought leaders looking to streamline their route to the clinic and scale up their manufacturing processes.

Event Links

Website: https://go.evvnt.com/2453698-0

Tickets: https://go.evvnt.com/2453698-2

Brochure: https://go.evvnt.com/2453698-3

Read More

View Less